Does SECUKINUMAB Cause Malignant melanoma? 185 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Malignant melanoma have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
185
Reports of Malignant melanoma with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
2
Deaths
13
Hospitalizations
How Dangerous Is Malignant melanoma From SECUKINUMAB?
Of the 185 reports, 2 (1.1%) resulted in death, 13 (7.0%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Malignant melanoma?
SILDENAFIL (1,248)
ADALIMUMAB (795)
TADALAFIL (741)
ETANERCEPT (495)
INFLIXIMAB (478)
METHOTREXATE (475)
DABRAFENIB (402)
LENALIDOMIDE (378)
RANITIDINE (352)
RITUXIMAB (291)
Which SECUKINUMAB Alternatives Have Lower Malignant melanoma Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG